A citation-based method for searching scientific literature

Fiona A Miller, Paul Krueger, Robert J Christensen, Catherine Ahern, Ronald F Carter, Suzanne Kamel-Reid. BMC Health Serv Res 2009
Times Cited: 27







List of co-cited articles
104 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Barriers to the use of personalized medicine in breast cancer.
Christine B Weldon, Julia R Trosman, William J Gradishar, Al B Benson, Julian C Schink. J Oncol Pract 2012
47
29

Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
264
25

Physicians' attitudes about multiplex tumor genomic testing.
Stacy W Gray, Katherine Hicks-Courant, Angel Cronin, Barrett J Rollins, Jane C Weeks. J Clin Oncol 2014
137
25

The path to personalized medicine.
Margaret A Hamburg, Francis S Collins. N Engl J Med 2010
946
18


Attitudes and practices among internists concerning genetic testing.
Robert Klitzman, Wendy Chung, Karen Marder, Anita Shanmugham, Lisa J Chin, Meredith Stark, Cheng-Shiun Leu, Paul S Appelbaum. J Genet Couns 2013
105
18

Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine.
Katherine Bonter, Clarissa Desjardins, Nathan Currier, Jason Pun, Fredrick D Ashbury. BMJ Open 2011
56
18

The primary care physician role in cancer genetics: a qualitative study of patient experience.
Fiona A Miller, June C Carroll, Brenda J Wilson, Jessica P Bytautas, Judith Allanson, Mario Cappelli, Sonya de Laat, Fred Saibil. Fam Pract 2010
24
16

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
Lyndsay Harris, Herbert Fritsche, Robert Mennel, Larry Norton, Peter Ravdin, Sheila Taube, Mark R Somerfield, Daniel F Hayes, Robert C Bast. J Clin Oncol 2007
14


Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.
Stacy W Gray, Elyse R Park, Julie Najita, Yolanda Martins, Lara Traeger, Elizabeth Bair, Joshua Gagne, Judy Garber, Pasi A Jänne, Neal Lindeman,[...]. Genet Med 2016
68
14

Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics.
Liza-Marie Johnson, Jessica M Valdez, Emily A Quinn, April D Sykes, Rose B McGee, Regina Nuccio, Stacy J Hines-Dowell, Justin N Baker, Chimene Kesserwan, Kim E Nichols,[...]. Cancer 2017
28
14

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L Baehner, Drew Watson, John Bryant,[...]. J Clin Oncol 2006
11

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
11

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011
152
11

Patients' and physicians' perspectives on pharmacogenetic testing.
Anja Rogausch, Daniela Prause, Anne Schallenberg, Jürgen Brockmöller, Wolfgang Himmel. Pharmacogenomics 2006
80
11


ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
11

Assessing patient readiness for the clinical adoption of personalized medicine.
A M Issa, W Tufail, J Hutchinson, J Tenorio, M Poonam Baliga. Public Health Genomics 2009
39
11

Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling.
Susanne B Haga, Madeline M Carrig, Julianne M O'Daniel, Lori A Orlando, Ley A Killeya-Jones, Geoffrey S Ginsburg, Alex Cho. J Gen Intern Med 2011
53
11


Molecular diagnostic strategies: a role in the practice of dermatology.
Zendee Elaba, Amanda Phelps, Michael J Murphy. Int J Dermatol 2012
4
75

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
Neal I Lindeman, Philip T Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire,[...]. J Thorac Oncol 2013
536
11

Genomic Profiling of Advanced Non-Small Cell Lung Cancer in Community Settings: Gaps and Opportunities.
Martin E Gutierrez, Kelly Choi, Richard B Lanman, Edward J Licitra, Stanley M Skrzypczak, Ruth Pe Benito, Tommy Wu, Srikesh Arunajadai, Sukhi Kaur, Harry Harper,[...]. Clin Lung Cancer 2017
78
11

Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings.
Kathleen R Blazer, Bita Nehoray, Ilana Solomon, Mariana Niell-Swiller, Julie O Culver, Gwen C Uman, Jeffrey N Weitzel. Genet Test Mol Biomarkers 2015
33
11

Has the revolution arrived?
Francis Collins. Nature 2010
164
7

Physicians' opinion for 'new' genetic testing in Japan.
Takako Ohata, Atsushi Tsuchiya, Maiko Watanabe, Tomohisa Sumida, Fumio Takada. J Hum Genet 2009
23
8

Is personalized medicine finally arriving?
Malorye Allison. Nat Biotechnol 2008
48
7

Confronting genetic testing disparities: knowledge is power.
Michael Hall, Olufunmilayo I Olopade. JAMA 2005
63
7

Disparities in genetic testing: thinking outside the BRCA box.
Michael J Hall, Olufunmilayo I Olopade. J Clin Oncol 2006
116
7



A health services research agenda for cellular, molecular and genomic technologies in cancer care.
Louise Wideroff, Kathryn A Phillips, Gurvaneet Randhawa, Anita Ambs, Katrina Armstrong, Charles L Bennett, Martin L Brown, Molla S Donaldson, Michele Follen, Sue J Goldie,[...]. Public Health Genomics 2009
14
14

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
Mark E Robson, Courtney D Storm, Jeffrey Weitzel, Dana S Wollins, Kenneth Offit. J Clin Oncol 2010
295
7


Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue.
Lida Mina, Sharon E Soule, Sunil Badve, Fredrick L Baehner, Joffre Baker, Maureen Cronin, Drew Watson, Mei-Lan Liu, George W Sledge, Steve Shak,[...]. Breast Cancer Res Treat 2007
58
7


Personalized medicine in the era of genomics.
Wylie Burke, Bruce M Psaty. JAMA 2007
134
7

Barriers to integrating personalized medicine into clinical practice: a best-worst scaling choice experiment.
Mehdi Najafzadeh, Larry D Lynd, Jennifer C Davis, Stirling Bryan, Aslam Anis, Marco Marra, Carlo A Marra. Genet Med 2012
25
8

Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey.
Yvonne Bombard, Gerry Veenstra, Jan M Friedman, Susan Creighton, Lauren Currie, Jane S Paulsen, Joan L Bottorff, Michael R Hayden. BMJ 2009
56
7

Beyond the patient: the broader impact of genetic discrimination among individuals at risk of Huntington disease.
Yvonne Bombard, JoAnne Palin, Jan M Friedman, Gerry Veenstra, Susan Creighton, Joan L Bottorff, Michael R Hayden. Am J Med Genet B Neuropsychiatr Genet 2012
27
7

Implementing genomic medicine in the clinic: the future is here.
Teri A Manolio, Rex L Chisholm, Brad Ozenberger, Dan M Roden, Marc S Williams, Richard Wilson, David Bick, Erwin P Bottinger, Murray H Brilliant, Charis Eng,[...]. Genet Med 2013
331
7

Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs.
Kathryn A Phillips, David L Veenstra, Scott D Ramsey, Stephanie L Van Bebber, Julie Sakowski. Am J Manag Care 2004
31
7

Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.
Rena Conti, David L Veenstra, Katrina Armstrong, Lawrence J Lesko, Scott D Grosse. Med Decis Making 2010
66
7

Attitudes of patients with cancer about personalized medicine and somatic genetic testing.
Stacy W Gray, Katherine Hicks-Courant, Christopher S Lathan, Levi Garraway, Elyse R Park, Jane C Weeks. J Oncol Pract 2012
74
7

Knowledge about genomic recurrence risk testing among breast cancer survivors.
Isaac M Lipkus, Susan T Vadaparampil, Paul B Jacobsen, Cheryl A Miree. J Cancer Educ 2011
17
11

Women's experiences with genomic testing for breast cancer recurrence risk.
Janice P Tzeng, Deborah Mayer, Alice R Richman, Isaac Lipkus, Paul K Han, Carmina G Valle, Lisa A Carey, Noel T Brewer. Cancer 2010
42
7

Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
Emily A Fargher, Charlotte Eddy, William Newman, Faieza Qasim, Karen Tricker, Rachel A Elliott, Katherine Payne. Pharmacogenomics 2007
73
7

Provision of personalized genomic diagnostic technologies for breast and colorectal cancer: an analysis of patient needs, expectations and priorities.
Amalia M Issa, Janis F Hutchinson, Waqas Tufail, Erica Fletcher, Roseline Ajike, Jose Tenorio. Per Med 2011
8
25

Cost-effectiveness analysis of recurrence score-guided treatment using a 21-gene assay in early breast cancer.
Daphne T Tsoi, Miho Inoue, Catherine M Kelly, Sunil Verma, Kathleen I Pritchard. Oncologist 2010
88
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.